Amazing T-type calcium channels: updating functional properties in health and disease by Bernd, Nilius & Emilio, Carbone
This is an author version of the contribution published on:
Bernd Nilius,Emilio Carbone
Amazing T-type calcium channels: updating functional properties in health
and disease
PFLUGERS ARCHIV (2014) 466
DOI: 10.1007/s00424-014-1481-7
The definitive version is available at:
http://link.springer.com/content/pdf/10.1007/s00424-014-1481-7
AMAZING T-TYPE CALCIUM CHANNELS: UPDATING 
FUNCTIONAL PROPERTIES IN HEALTH AND DISEASE 
 
Bernd Nilius
*
 and Emilio Carbone
#+
 
 
*
KU Leuven, Department of Cellular and Molecular Medicine, Laboratory Ion Channel 
Research, Campus Gasthuisberg, Herestraat 49, bus 802, Leuven, Belgium 
 
#
Department of Drug Science, Laboratory of Cellular & Molecular Neuroscience, NIS 
Center, CNISM, University of Torino, 10125 Torino, Italy 
+
corresponding author 
 
 
Abstract 
T-type Ca
2+
 channels have gained 15 years after cloning an immense interest as novel 
players in very unexpected cell functions and many relations to diseases have been 
discovered. This Special Issue provides a state of the art overview on novel functional 
properties of T-type Ca
2+
 channels, unexpected cellular functions and most importantly 
will also summarizes and review the involvement of this “tiny, transient” type of Ca2+ 
channels in several disease. It is tried to bridge the gap between molecular biophysical 
properties of T-type Ca
2+
 channels and diseases providing finally a translational view on 
this amazing ion channel.  
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The advent of T-type Ca
2+
 channels 
 
Calcium ions function as the most widespread, versatile and promiscuous signalling 
molecule within intracellular cell compartment. Changes in the concentration of free 
cytosolic Ca
2+
 ([Ca
2+
]i) are of fundamental importance in gene expression, different 
stages of the cell cycle, starting from the fertilization and embryonic pattern formation 
over cell differentiation and proliferation to cell death and cell necrosis. Modulation of 
[Ca
2+
]i is essential for different cellular processes such as gene transcription, transmitter 
release, muscle contraction, secretion, learning and memory (3). It is known since the 
early 1950th that a major part of these changes in [Ca
2+
]i depend on a Ca
2+
 influx via the 
plasma membrane (see for an concise overview 33). However, the first Ca
2+
 currents, 
recorded with a double sucrose gap voltage clamp device, were described only on 1967 
(39). It became clear, especially after refining the electrophysiological methods (19, 22) 
that Ca
2+
 permeates through highly selective Ca
2+
 channels. The accepted paradigm was 
that probably only “a” Ca2+ channel existed, although a first indication of the presence of 
a heterogeneity of Ca
2+
 channel populations was obtained already in 1975 (18) using a 
two-electrode voltage clamp  method in starfish eggs. However, the first clear evidence 
for functionally different highly Ca
2+
 selective channels came in 1984–85. The so called, 
low-voltage-activated (LVA) or T-type (from “tiny” and “transient”) Ca2+ channels were 
directly measured as single channel events by using the patch-clamp technique in sensory 
neurones (6, 34) and ventricular myocytes (32). Fast inactivating burst-like openings 
were detected at very low voltages in excised membrane patches of sensory neurons with 
activation-inactivation kinetics and holding sensitivity very similar to that of macroscopic 
low-threshold currents (see figure 2 in 6). The clear-cut separation between high-voltage 
activated (HVA) or L-type (from “large” and “long-lasting”) and T-type channels in 
single channel measurements, occurred soon after and came as a surprise. If Ba
2+
 was the 
charge carrier, long-lasting openings representing the ~25 pS L-type channel could be 
easily resolved even in the same patch from burst-like openings representing T-type Ca
2+
 
channels of ~7 pS (see e.g. figure 3 in 32). The tiny single channel conductance with both 
Ba
2+
 or Ca
2+
 being the charge carrier through T-type channel was later confirmed an 
many other studies (8, 13). In this period, it was also evident that besides activating 
transiently at very negative membrane potentials (2, 6, 14), the neuronal T-type channel 
possessed two other unique key properties: a very slow deactivation rate (1, 5) and an 
effective recruitment of full size low-threshold Ca
2+
 currents following short 
hyperpolarization (7, 11). Both features, could nicely account for the existence of Ca
2+
-
mediated rebound spikes observed in the inferior olive and thalamic neurons (25-27) , 
named  “low-threshold Ca2+ spikes” (see for a recent review 23).. This feature was also 
described at the single channel level in cardiac myocytes (13). Interestingly, some 
unexpected single channel properties, e.g. the voltage dependence of the first latency for 
single channel openings, could be nicely translated into the macroscopic voltage 
dependent inactivation of T-type Ca
2+
 channels (13).  
In the same period (1985-89), the canonical biophysical properties of neuronal and 
cardiac T-type channels were established (2, 4, 8, 13, 14, 16) and it was also clearly 
anticipated that possibly several genes were responsible for encoding different types of 
Ca
2+
 channels. Now, we know that 10 genes encode for the pore forming-subunit of 
different Ca
2+
 selective ion channels (1S, C, D, F, A, B, E and for T-type 1G, H, I). In 
addition, we also know that 10 genes for non-pore forming Ca
2+
 channel subunits exist 
(1-4, 1-4, 1, 6) which modulate the functional properties and the expression pattern 
of Ca
2+
 channels, but have not been proven so far to play a role for T-type channels (for 
the most recent review see 20). 
 
T-type Ca
2+
 channels: molecular identity and selective antagonists 
 
Surprisingly, it took more than 10 years before the three T-type Ca
2+
 channel genes were 
identified (29, 35-37). Three 1-subunits were cloned (1G, 1H and 1I or Cav3.1, 
Cav3.2 and Cav3.3), which were further extended by alternative splicing (36). This was a 
decisive step to allow the unraveling of structural determinants for permeation and kinetic 
T-type channel properties (41, 44). Even more exciting, the functional role of T-type Ca
2+
 
channels could now be studied systematically, the distribution and expression pattern of 
the three T-type isoforms in several tissues could be unraveled, and, importantly, opened 
the possibility to use antisense and knock-out strategies to unveil the physiological and 
pathological role of these channel (for some reviews from the early period after cloning 
see 15, 33, 35, 36, 42, 43). The molecular cloning of the T-type Ca
2+
 channels is now 
approximately 15 years old and has been so far the focus of the new developments in this 
exciting field.  
Amazingly enough, it took even longer (24 years!) to develop a new generation of 
selective T–type channel blockers (40) that could overcome the weak specificity of anti-
hypertensive drugs (mibefradil) (9, 30) and divalent cations (Ni
2+
) toward T-type 
channels. Mibefradil and Ni
2+
 have been for years the only pharmacological tools on 
hands of physiologists and pharmacologists to dissect the effects of T-type from other 
voltage-gated channels. Their usage, however, was often limited to a qualitative 
identification of T-type channel expression for specific cellular functions, particularly 
when Ca
2+
 currents could not be directly measured. It is not surprising, therefore that the 
recent synthesis of piperidine derivatives (TTA-P2) (40), which potently and selectively 
block T-type channels (12), boosted the number of reports on T-type channels in the last 
5 years and allowed the discovery of unexpected cell functions in which low-voltage 
activated channels are involved (21, 28). 
T-type channels are now recognized as therapeutic targets in a variety of diseases, like 
epilepsy, insomnia, pain, cancer and hypertension (for recent reviews see 38). It can thus 
be predicted that present and future Ca
2+
 channel antagonists selective for Cav3 channels 
will be increasingly used to better understand the role of these channels in the regulation 
of key body functions with a search for clinical products. 
 
A Special Issue on T-type Ca
2+
 channels: amazing new functional roles 
 
The first ideas about a functional impact of T-type Ca
2+
 channels came from heart muscle 
and central neurons rhythmicity. In one case, the T-type channel has been hypothesized 
to play a critical role in cardiac pacemaking (17, 31). In the other case, T-type channel 
was essential for the synchronized repetitive activity of thalamic neurons (10, 25) 
characteristic of certain stages of sleep (see for an historical overview 24). Later, T-type 
channels were considered as important for smooth muscle contraction, hormone and 
neurotransmitter secretion, gamete interaction and gene expression (discussed in a 
historical overview on T-type channel in 33). Research in the last 10 years has indicated a 
plethora of new cell functions in which T-type Ca
2+
 channels are involved. 
This special issue of Pflügers Archiv focuses on the multiple roles that T-type channels 
play in the regulation of critical body functions. T-type channels control neuronal 
excitability, muscle contraction, hormone and neurotransmitter release, pain sensation, 
cell development and proliferation. Thus, it is not surprising that up- or down-regulation 
or critical mutations of Cav3 channels can cause neurodegenerative diseases (epilepsy, 
sleep disorders, stress, hyperalgesia), as well as tumor growth and cardiovascular diseases 
(cardiac arrhythmias, heart block and hypertension). In this special issue we have 
therefore given equal emphasis to the new functional roles of T-type channels and to the 
search of newly available T-type channel antagonists with potential use in the therapy. 
In the first article related to the structure and function of Cav3.1, Cav3.2 and Cav3.3 
channels Dr Edward Perez-Reyes discusses the importance of two critical regions of the 
channel: the extracellular high affinity metal binding site and the intracellular loop 
connecting repeats I and II (the “gating brake”) which stabilizes Cav3 channel gating and 
regulates surface channel expression. Dr. Yaroslav Shuba then describes the mechanism 
by which Ca
2+
 ions permeate through open Cav3 channels and how the intrapore binding 
sites for Ca
2+
 of LVA channels differs from that of HVA channels. Along these lines, Dr. 
David Spafford compares the impressive similar structure and function of Cav3 channels 
of invertebrates and mammals providing insights into key shared features between these 
distant channels.  
In relation to the interaction of T-type channels with other ion channels, membrane 
proteins or bioactive lipids, Drs. Ray Turner and Gerald Zamponi focus on the newly 
discovered property of T-type to form signaling complexes with different calcium-gated 
(KCa1.1 and KCa3.1) and even with voltage-gated K
+
 channels via associated KChIP 
proteins, broadening the regulatory role of Cav3 channels in neuronal excitability. Dr. 
Emilio Carbone discuss new emerging views on the role of T-type channels in controlling 
synaptic transmission in central neurons and vesicular exocytosis in neuroendocrine cells 
in the light of recent reports on the co-localization of T-type channels with ion channels, 
membrane receptors and SNARE proteins. Drs. Jeanne Chemin and Philippe Lory 
describe the inhibitory effects of various endogenous lipids on Cav3.2 and Cav3.3 
channels and how these modulatory effects could be critically associated with pain 
sensation and vasodilation. 
Concerning the involvement of T-type channels in neurodegenerative diseases, Dr. 
Slobodan Todorovic provides a detailed overview of the role that T-type channels play in 
the increased sensitization of pain response in animal models of type 1 and type 2 
peripheral diabetic neuropathy. Dr. Emmanuel Bourinet discusses the role of T-type in 
the perception and modulation of pain and how recent T-type channel blockers could be 
possibly used as new analgesic. Dr. Hee-Sup Shin focuses on recent studies on the T-type 
channels in absence epilepsy showing that T-type channels of excitatory thalamocortical 
neurons rather than T-type channels of the inhibitory thalamic reticular nuclei are crucial 
for the generation of spikes and wave discharges at the origin of the disease. On the same 
topic, Drs. Régis Lambert, Nathalie Leresche and Vincenzo Crunelli discuss how the use 
of selective T-type channel blockers helps understanding the key function of T-type 
“window current” in the control of slow waves and spindles of natural sleep in thalamic 
neurons. Dr. Chung-Chin Kuo provides new emerging evidence on the role of T-type 
window current in the genesis of bursts discharges in neurons of subthalamic nucleus of 
parkinsonian models and how T-type channel antagonists could be beneficial for the 
treatment of Parkinson’s disease. In relation to the neuroprotective action of T-type 
channel blockers, Dr. Janxin Bao describes in details the efficacy of newly developed 
chemical compounds with promising neuroprotective effects.  
Regarding the T-type channels expressed in the cardiovascular system, Dr. Cary Hill 
discusses the peculiar properties of Cav3 channels and their coupling to Ca
2+
-gated K
+
 
channels in smooth muscle tissues and how their rapid up- or down-regulation can affect 
peripheral vasoconstriction. In line with this, Dr. Christopher Fry furnishes a detailed 
description of T-type channels expressed in the muscle and epithelial tissues of the 
urinary and male genital tracts and how an up-regulation of their activity could induce 
functional disorders (prostate tumors). Dr. Matteo Mangoni describes the relevance of T-
type channels in impulse conduction and heart rate automaticity of sino-atrial and atrio-
ventricular nodes using mice models, discussing their significance in the light of recent 
studies on the role of T-type channels in congenital heart block in humans. 
Concerning the specific involvement of T-type channels in cancer, Dr. Jaroslav 
Dziegielewski discusses recent findings which identify the T-type channels as the 
molecular target for anticancer therapy and indicate new directions for the design of 
novel therapeutic strategies using T-type channel antagonists. Along this line, Dr Jin Tao 
focuses on the use of T-type channel blockers for the treatment of highly proliferative 
tumors like glioblastoma. Drs. Alberto Darzson and Arturo Hernandez-Cruz complete the 
issue providing a detailed description of the evidence for the role of Cav3 channels in 
spermatogenic cells and in spermatozoa  
Obviously, this reviews collection of world's leading T-type channel researchers does not 
cover all the many exciting aspects on the structure and function of Cav3 channels. It 
certainly provides a topical overview of pertinent issues that will be further developed in 
future studies, hopefully with the entry of new research groups. 
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